You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Small lung cancer

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Squamous Non-Small Cell Lung Carcinoma Trial in Chicago (Cabozantinib 40 MG, Pembrolizumab 200mg)

Recruiting
  • Metastatic Squamous Non-Small Cell Lung Carcinoma
  • Cabozantinib 40 MG
  • Pembrolizumab 200mg
  • Chicago, Illinois
    University of Illinois at Chicago
Jan 20, 2023

Advanced Squamous Non Small Cell Lung Cancer Trial (AK112, Carboplatin, Paxlitaxel, Tislelizumab, Carboplatin, Paxlitaxel)

Not yet recruiting
  • Advanced Squamous Non Small Cell Lung Cancer
  • AK112, Carboplatin, Paxlitaxel
  • Tislelizumab, Carboplatin, Paxlitaxel
  • (no location specified)
Apr 21, 2023

NSCLC, Metastatic NSCLC Trial (Tislelizumab, BGB-A445, LBL-007)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Metastatic Non-small Cell Lung Cancer
  • (no location specified)
Dec 14, 2022

Non-small-cell Lung Cancer Trial (HL-085+Vemurafenib)

Not yet recruiting
  • Non-small-cell Lung Cancer
  • (no location specified)
Jun 8, 2023

NSCLC Trial (Anlotinib Hydrochloride, penpulimab, SBRT)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Anlotinib Hydrochloride
  • +2 more
  • (no location specified)
Aug 2, 2022

Advanced or Metastatic Squamous NSCLC Trial in Sydney (HMBD-001, Docetaxel, Cetuximab)

Not yet recruiting
  • Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 20, 2023

NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 17, 2023

Metastatic Non Small Cell Lung Cancer Trial in Japan (Datopotamab Deruxtecan, Pembrolizumab, Pemetrexed)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Datopotamab Deruxtecan
  • +4 more
  • Fukuoka, Japan
  • +3 more
Jan 13, 2023

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations Trial in

Recruiting
  • Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
  • Canton, Ohio
    Gabrail Cancer and Research Center
Jul 21, 2023

Emulation of KEYNOTE-189 Trial Using Electronic Health Records

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Metastatic Lung Cancer
  • Boston, Massachusetts
    Aetion
Jun 14, 2023

Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples

Recruiting
  • Non-squamous Lung Cancer
  • Metastatic Lung Cancer
  • Blood
  • +3 more
  • Tours, France
    University hospital
Nov 7, 2022

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation Trial in Canton (TAS6417)

Recruiting
  • Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
  • Canton, Ohio
    Gabrail Cancer and Research Center
Jul 25, 2023

Advanced NSCLC Trial in Spokane (Zimberelimab, Domvanalimab, Quemliclustat)

Recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Spokane, Washington
    Medical Oncology Associates
Jan 5, 2023

Lung Cancer, Lung Cancer Metastatic, Brain Metastases Trial in Sacramento ([18F]-avß6-BP)

Recruiting
  • Lung Cancer
  • +3 more
  • Sacramento, California
    The University of California Davis Comprehensive Cancer Center
Aug 3, 2022

Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Patritumab deruxtecan
  • (no location specified)
May 9, 2023

NSCLC Trial in France (TG6050)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Bordeaux, France
  • +3 more
Mar 15, 2023

Non Small Cell Lung Cancer Metastatic Trial (Pembrolizumab in Combination with Plinabulin and Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • Pembrolizumab in Combination with Plinabulin and Docetaxel
  • (no location specified)
Oct 28, 2022

Non Squamous Non Small Cell Lung Cancer Trial in Korea, Republic of (Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin)

Not yet recruiting
  • Non Squamous Non Small Cell Lung Cancer
  • Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin
  • Anam, Korea, Republic of
  • +7 more
May 1, 2023

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

NSCLC Metastatic Trial in Shanghai (Almonertinib, SBRT)

Recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 23, 2023

NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Nov 7, 2023

Advanced or Metastatic NSCLC Trial in Moscow, Saint Petersburg, St. Petersburg (Ceralasertib, Durvalumab)

Recruiting
  • Advanced or Metastatic NSCLC
  • Moscow, Russian Federation
  • +7 more
Jul 4, 2023

NSCLC Trial in United States (ALT-803, Nivolumab)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • ALT-803
  • Nivolumab
  • Weston, Florida
  • +3 more
Dec 5, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
May 1, 2023

Stage IV NSCLC Trial in Palo Alto (Immunotherapy (physician's choice for standard of care immunotherapy), Image-guided Radiation

Active, not recruiting
  • Stage IV Non-Small Cell Lung Cancer
  • Immunotherapy (physician's choice for standard of care immunotherapy)
  • Image-guided Radiation Therapy
  • Palo Alto, California
    Stanford University, School of Medicine
Aug 17, 2022